The end of 2019 was a proud moment for us at Gondola Medical Technologies. We won a 2.5 million research grant from Horizon 2020<\/a> (EIC Accelerator Award<\/a>) from the European Commission. This grant is a sign of trust that has helped us strengthen our activities as a company.<\/p>\n\n\n\n The GONDOLA treatment\u00ae<\/sup>\u00a0AMPS is a non-invasive, side-effect-free therapy for neurological conditions that cause gait and balance disorders. It helps patients regain independence, move better and live better.<\/p>\n\n\n\n Moving our headquarters from Ticino to the\u00a0Biop\u00f4le<\/a>\u00a0of Lausanne is strategic for our development as a MedTech company. In fact, Biop\u00f4le is a first-class science park, renowned in Switzerland and internationally, and we are proud to be part of its life science community. Over the past year, our team has grown from 5 to 17 employees, increasing our scientific research, marketing, and sales activities.<\/p>\n\n\n\n In addition to the launch of version 3.0 of the GONDOLA device.\u00ae <\/sup>designed for home use, a more user-friendly version, and scalable volumes, we have expanded the use of our AMPS treatment from Parkinson's disease alone to other neurological disorders such as stroke and cerebral palsy as well as spinal stroke and other conditions.<\/p>\n\n\n\n Geographic expansion into new markets, namely Germany, France and Spain, is well underway. At Gondola Medical Technologies, we look forward to further expanding the GONDOLA network.\u00ae<\/sup> of partner centers in Germany. \u00e8er now + all we can share.<\/p>\n\n\n\n Gondola Medical Technologies has received the Growth Tech Loan of CHF 500,000 from FIT (Fondation pour l'innovation technologique) based at EPFL Lausanne. The loan is coming in two installments; CHF 200,000 up front, followed by CHF 300,000 based on a pivotal plan presented to the FIT selection committee. These funds will be dedicated to research and development, which includes the growth of the clinical research team and its studies.<\/p>\n\n\n\n Despite the impact Covid-19 has had on clinical research activities, there are new studies in our research plans: one in collaboration with the\u2019Uniklinik de Cologne<\/a> in Germany and Lausanne University Hospital (CHUV<\/a>) in Switzerland.<\/p>\n\n\n\n Stay tuned for more!<\/p>","protected":false},"excerpt":{"rendered":" With the arrival of the research grant, we have been very busy at GONDOLA. In this article we share the milestones we have achieved in the past 365 days and exciting new projects and activities we are working on.<\/p>","protected":false},"author":3,"featured_media":29712,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-30731","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other"],"_links":{"self":[{"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/posts\/30731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/comments?post=30731"}],"version-history":[{"count":0,"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/posts\/30731\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/media\/29712"}],"wp:attachment":[{"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/media?parent=30731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/categories?post=30731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gondola-medical.com\/en\/wp-json\/wp\/v2\/tags?post=30731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}The headquarters at the Biopole in Lausanne<\/h2>\n\n\n\n
Scope of treatment and new markets<\/h2>\n\n\n\n
FIT's Growth Tech Loan<\/h2>\n\n\n\n
Clinical research study<\/h2>\n\n\n\n